marketresearchtrends

COVID Testing Kit Market COVID Testing Kit Market size is expected to reach USD 122.82 Billion by 2030 at a CAGR of 7.20% during the forecast period 2022-2030, The COVID testing kits market has witnessed massive growth in recent times. The market growth is being driven by the developments & support by non-medical device/diagnostic companies, increasing number of emergency use authorizations for diagnostic kits & devices, government & private funds, support for research & development, and a rising number of COVID-19 cases. However, the market growth is anticipated to be restricted by the accuracy of tests and restrictions on the export of diagnostic kits. Major Key Players: MRFR recognizes the COVID Testing Kit Market Players are — Abbott (US), BioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Chembio Diagnostic Systems, Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), GenMark (US), Henry Schein, Inc. (US), Thermo Fisher Scien...

  COVID Testing Kit Market According to the latest data, there were 86,827 new cases on 16 May 2020 and 7,215,102 new cases on 8 June 2020, globally. Due to such increasing numbers of cases, there is a growing demand for more COVID-19 testing kits and devices, hence driving the market growth. Global  COVID Testing Kit Market  is expected to have a market value of  USD 97,903.2 Million  by 2027. Major Key Players: MRFR recognizes the following companies as the Key Players in the Global COVID Testing Kit— Abbott (US), BioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Chembio Diagnostic Systems, Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), GenMark (US), Henry Schein, Inc. (US), Thermo Fisher Scientific Inc. (US), Qiagen (Germany), Siemens AG (Germany), Guangzhou Wondfo Biotech (China), Robert Bosch GmbH (Germany), Cellex (US), Mayo Clinic Laboratories (US), Mount Sinai Laboratory (US), Zhejiang Orient Gene Biotech Co., Lt...